AU Patent

AU2013203566B2 — Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides

Assigned to Onyx Therapeutics Inc · Expires 2016-10-13 · 10y expired

What this patent protects

The invention relates to crystalline peptide keto epoxide compounds, methods of their preparation, and related pharmaceutical compositions. This invention also relates to methods for the preparation of amino acid keto-epoxides. Specifically, allylic ketones 5 are stereoselectivel…

USPTO Abstract

The invention relates to crystalline peptide keto epoxide compounds, methods of their preparation, and related pharmaceutical compositions. This invention also relates to methods for the preparation of amino acid keto-epoxides. Specifically, allylic ketones 5 are stereoselectively converted to the desired keto epoxides.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013203566B2
Jurisdiction
AU
Classification
—
Expires
2016-10-13
Drug substance claim
No
Drug product claim
No
Assignee
Onyx Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.